PAG
Private Advisor Group’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-41,781
| Closed | -$1.93M | – | 2266 |
|
|
2021
Q4 | $1.93M | Sell |
41,781
-1,061
| -2% | -$49K | 0.01% | 824 |
|
|
2021
Q3 | $2.03M | Buy |
42,842
+14,474
| +51% | +$687K | 0.01% | 875 |
|
|
2021
Q2 | $1.47M | Buy |
28,368
+377
| +1% | +$19.5K | 0.01% | 876 |
|
|
2021
Q1 | $1.41M | Buy |
27,991
+414
| +2% | +$20.8K | 0.01% | 851 |
|
|
2020
Q4 | $1.44M | Buy |
+27,577
| New | +$1.44M | 0.02% | 772 |
|
|
2020
Q3 | – | Sell |
-1,750
| Closed | -$75K | – | 3452 |
|
|
2020
Q2 | $75K | Buy |
+1,750
| New | +$75K | ﹤0.01% | 1879 |
|
|
2018
Q3 | – | Sell |
-21,759
| Closed | -$939K | – | 1657 |
|
|
2018
Q2 | $939K | Buy |
+21,759
| New | +$939K | 0.02% | 505 |
|
|
2016
Q1 | – | Sell |
-4,506
| Closed | -$231K | – | 1144 |
|
|
2015
Q4 | $231K | Buy |
4,506
+115
| +3% | +$5.9K | 0.01% | 884 |
|
|
2015
Q3 | $206K | Buy |
4,391
+2,552
| +139% | +$33.5K | 0.01% | 876 |
|
|
2015
Q2 | $229K | Buy |
+1,839
| New | +$229K | 0.01% | 892 |
|
|
2014
Q4 | – | Sell |
-244
| Closed | -$26K | – | 1282 |
|
|
2014
Q3 | $26K | Buy |
+244
| New | +$26K | ﹤0.01% | 1114 |
|
|
2014
Q1 | – | Sell |
-32,218
| Closed | -$2.83M | – | 851 |
|
|
2013
Q4 | $2.83M | Buy |
+32,218
| New | +$2.83M | 0.32% | 68 |
|